These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A simple nomogram for predicting infectious diseases in adult kidney transplantation recipients. Chen RY; Zhang S; Zhuang SY; Li DW; Zhang M; Zhu C; Yu YT; Yuan XD Front Public Health; 2022; 10():944137. PubMed ID: 36117592 [TBL] [Abstract][Full Text] [Related]
8. Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa. Wagh H; Arif A; Reddy AJ; Tabaie E; Shekhar A; Min M; Nawathey N; Bachir M; Brahmbhatt H Cureus; 2022 Jul; 14(7):e26600. PubMed ID: 35936184 [TBL] [Abstract][Full Text] [Related]
9. The Role of Complement in HSCT-TMA: Basic Science to Clinical Practice. Meri S; Bunjes D; Cofiell R; Jodele S Adv Ther; 2022 Sep; 39(9):3896-3915. PubMed ID: 35781192 [TBL] [Abstract][Full Text] [Related]
10. A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key. Ferdjallah A; Young JH; MacMillan ML Front Pediatr; 2021; 9():634449. PubMed ID: 34386464 [TBL] [Abstract][Full Text] [Related]
11. Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach. Horowitz JG; Gawrys GW; Lee GC; Ramirez BA; Elledge CM; Shaughnessy PJ Transpl Infect Dis; 2021 Aug; 23(4):e13689. PubMed ID: 34255395 [TBL] [Abstract][Full Text] [Related]
12. Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation. Lee A; Hong J; Shin DY; Koh Y; Yoon SS; Kim PJ; Kim HG; Kim I; Park HK; Choi Y J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32290456 [TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Whangbo J; Ritz J; Bhatt A Bone Marrow Transplant; 2017 Feb; 52(2):183-190. PubMed ID: 27526283 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation. Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140 [TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis. Alonso CD; Marr KA Curr Opin Infect Dis; 2013 Aug; 26(4):326-31. PubMed ID: 23806895 [TBL] [Abstract][Full Text] [Related]
18. Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today? Horton LE; Haste NM; Taplitz RA Curr Hematol Malig Rep; 2018 Feb; 13(1):59-67. PubMed ID: 29374371 [TBL] [Abstract][Full Text] [Related]